Please contact Madeline Bacon with any questions.
Mail: The Rubin Institute for Advanced Orthopedics
Sinai Hospital of Baltimore
2401 West Belvedere Avenue
Baltimore, Maryland 21215, USA
|You can register online or by printing out the registration form and sending the completed form to the fax number or to the mailing address that is listed on the form. If you are not using your own credit card to pay the registration fee or you are using your credit card to pay for multiple registration fees, please complete this form.
Click here to view a PDF of the course brochure.
The course venue is the Four Seasons Hotel
(200 International Drive) in the heart of Baltimore’s Inner Harbor. The
discounted per-room fee for course attendees is $207 per night (plus
tax). It is highly recommended that you make your reservations early
(discounted rate offered on a space-available basis through July 21,
2014). To make a reservation, visit the hotel web site,
select the dates of your reservation, click on "Corporate/Promo Code,"
and then enter code "INSI0819." You can also call 1.410.576.5800, ask
for in-house reservations, and mention “Sinai 8th Annual Hip and Knee
Conference” to receive the discounted group rate.
those driving to the Four Seasons Hotel each day, we have arranged for a discounted
daytime valet parking rate of $8/day. This rate does not apply to
self-park during the day or to overnight parking (currently $40 for
valet and $23 for self-park per night).
The Eighth Annual Hip and Knee Course:
New Technology for the Treatment of Adult Hip and Knee Disorders
Date: August 15–16, 2014
Location: Four Seasons Hotel, Baltimore, Maryland
Michael A. Mont, MD
Thomas P. Schmalzried, MD
Ronald E. Delanois, MD
James Nace, DO
AMA PRA Category 1 CreditsTM: 13
This conference will bring together the world leaders in hip and knee joint preservation and reconstruction. The course format will consist of fast paced, lively discussions, didactic presentations, and surgical case presentations. The goal is to identify, outline, and discuss the current state of knowledge in the clinical and basic sciences as they pertain to the diagnosis and treatment of hip and knee disorders in adult patients.
Topics discussed will include the latest technology, surgical approaches, techniques, prostheses, computer-assisted surgery/robotics, and the business of total joint arthroplasty in our new health care environment. General topics will include infection, revision, how to manage defects, patient selection, and bone deficiency.
Surgical approaches to the hip that will be taught will include the anterior, anterolateral, and posterior approaches. Comparisons will be made among different bearing surfaces, such as polyethylene, ceramic-on-ceramic, ceramic-onpolyethylene, and metal-on-metal. Stem selection for primary and revision total hip arthroplasty will be presented. Faculty will examine options to treat bone deficiency and the presence of metal ions.
During the sessions on knee arthroplasty, compression-molded, highly cross-linked, and vitamin E polyethylene will be introduced. The use of custom blocks and custom components will be considered. Faculty will discuss the merits and flaws of cementing versus press-fit technology and whether infected knee arthroplasty should be treated with static or mobile spacers. Faculty will also present a comprehensive range of materials to manage defects, including morselized bone graft, cement, bulk allograft, and cones. Patient selection and implant options for patellofemoral arthroplasty will be discussed.
- Identify new and currently available technology to treat adult hip and knee disorders
- Discuss the current state of knowledge in joint preservation and reconstruction
- Understand current and emerging surgical and nonsurgical approaches for the treatment of arthritis in the hip and in the knee
- Evaluate therapies and new approaches for relieving pain and improving function
- See the future directions of joint preservation in an ever-changing world
Pre-Course Hip and Knee Cadaver Lab: New Innovations in Total Knee Arthroplasty and Direct Anterior versus Watson-Jones Approach
Date: Thursday, August 14, 2014
Chair: Ronald E. Delanois, MD
AMA PRA Category 1 CreditsTM: 7.25
Participants will gain first-hand experience in cadaveric dissections using various techniques for the treatment of arthritis and joint preservation of the hip and knee joints. The morning session will be dedicated to the latest advances in the direct anterior and Watson Jones approaches of the hip. The afternoon will cover new innovations in total knee arthroplasty. Due to the low ratio of surgeons to specimens, registration is limited. Transportation between the anatomy lab and the Four Seasons Hotel will be provided.
- Practice primary total hip arthroplasty using the direct anterior and Watson Jones techniques that allow increased extensile exposure of the hip and wide exposure of the proximal femoral diaphysis.
- Learn how to perform minimally invasive unicompartmental arthroplasty while preserving the maximum amount of normal tissue.
- Gain an understanding of innovative techniques that are used to perform total knee arthroplasty.
Accreditation Statement for CME: LifeBridge Health is accredited by MedChi, the Maryland State Medical Society, to provide continuing medical education for physicians.
Designation Statement: LifeBridge Health designates this live educational activity for a maximum of 20.25 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure Policy: It is the policy of Sinai Hospital of Baltimore, a LifeBridge Health Center, to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support of Continuing Medical Education. All faculty participating in sponsored or jointly sponsored programs by Sinai Hospital of Baltimore are required to disclose to the program audience any real or apparent conflict(s) of interest related to the content of their presentation(s). In accordance with the ACCME requirements on disclosure information, relationships of presenters with commercial interests (if any) will be included in materials distributed at the time of the Course.
CME Committee Disclosures: The following LifeBridge Health Continuing Medical Education Committee members and their spouses/partners have no financial interest or affiliation with the manufacturer or distributor of any medical products, devices or services: Madeline Bacon; Joseph Berkow, MD; Eric Buchner, MD; John Cmar, MD; Lee Cook; Thomas Genuit, MD; Tina Gionet; Mark Katlic, MD; Lorrie Liang; Diane Maloney-Krichmar, PhD; Andrew Mayrer, MD; Allan Pristoop, MD; Wendy Robinson; and Richard Rohrs, PA-C. However, David Gordon, MD, receives grant/research support and is a consultant for ACell, Allergan, Astellas, and UroVal, and is also on the speakers bureau for ACell, Allergan, American Medical System (AMS), Astellas, Pfizer, UroVal, and Warner Chilcottt; Asha Thomas, MD, is the primary investigator for Bydureon/Lilly, co-investigator for Corlux/Corcept Therapeutics and Samsca/Otsuka; and Joseph Wiley, MD, is on the speakers bureau for Pfizer and Sigma Tau and receives grant/research support from Children’s Oncology Group.
"Thank you for allowing us to attend your course! It pointed out some deficiencies in my knowledge."
"Drs. Delanois, Mont, and Schmalzried have done an excellent job. This course is a wonderful service to our orthopedic community/training programs. Good conference, I'm coming every year!"
"Great format - kept me interested."
"I enjoyed the increased number of cases this year. Especially after the lectures, as they reiterated the ideas that were just presented."